Related Experiment Video

Updated: May 9, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Significant increase in plasma 4β-hydroxycholesterol concentration in patients after kidney transplantation

Yosuke Suzuki1, Hiroki Itoh, Fuminori Sato

  • 1Department of Clinical Pharmacy Faculty of Medicine, Oita University, Hasama-machi, Oita 879-5593, Japan. y-suzuki@oita-u.ac.jp

Journal of Lipid Research
|July 9, 2013
PubMed

Insights

Kidney transplantation in end-stage renal disease patients may restore liver drug metabolism. This study shows improved kidney function after transplantation correlates with recovery of CYP3A activity, crucial for drug clearance.

Area of Science:

  • Pharmacology
  • Nephrology
  • Hepatology

Background:

  • Renal failure impairs drug metabolism, especially for drugs cleared by Cytochrome P450 3A (CYP3A).
  • The impact of renal function recovery on hepatic CYP3A activity post-kidney transplantation is not well understood.

Purpose of the Study:

  • To investigate the effect of improved renal function on CYP3A activity in end-stage renal disease (ESRD) patients after kidney transplantation.
  • To assess the recovery of metabolic clearance pathways following renal allograft transplantation.

Main Methods:

  • The study included 13 ESRD patients undergoing their first kidney transplantation.
  • Plasma 4β-hydroxycholesterol concentrations, a biomarker for CYP3A activity, were measured serially using GC-MS before and up to 180 days post-transplantation.
  • Creatinine clearance was monitored to assess renal function recovery.

Main Results:

  • Creatinine clearance significantly increased from day 3 post-transplantation and remained stable.
  • Plasma 4β-hydroxycholesterol levels showed a significant elevation at 90 and 180 days after kidney transplantation, indicating restored CYP3A activity.

Conclusions:

  • This study suggests that recovery of renal function following kidney transplantation in ESRD patients is associated with the restoration of hepatic CYP3A activity.
  • Improved renal function may lead to improved metabolic clearance of CYP3A-metabolized drugs in these patients.
Keywords:
CYP3A activityend-stage renal diseaseplasmarenal failure

More Related Videos

Murine Kidney Transplant Technique08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...